Skip to main navigation Skip to search Skip to main content

Biomarin Presents Findings From Studies Of Valoctocogene Roxaparvovec, Investigational Gene Therapy, At The International Society On Thrombosis And Haemostasis (ISTH) 2022 Congress July 9-12, Including 4 Oral And 2 Poster Presentations'

Press/Media

Period11 Jul 2022

Media coverage

1

Media coverage

  • TitleBiomarin Presents Findings From Studies Of Valoctocogene Roxaparvovec, Investigational Gene Therapy, At The International Society On Thrombosis And Haemostasis (ISTH) 2022 Congress July 9-12, Including 4 Oral And 2 Poster Presentations'
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date11/07/22
    PersonsSuresh Agarwal
View all 1
View less